Investigation of the effect of visceral adiposity index on venous clinical severity score in patients with chronic venous insufficiency
INTRODUCTION: Chronic venous insufficiency (CVI) is a common disease affecting millions worldwide. Age, obesity, female gender, sedentary life, and long-standing at work causing orthostasis have been identified as predisposing factors.
OBJECTIVE: The visceral adiposity index (VAI) is an important indicator of abdominal obesity. Various studies in the cardiovascular field have shown that it may be more predictive than body mass index (BMI).
METHODS: A total of 171 consecutive patients diagnosed with low-grade (C0-C3) superficial primary CVI in our clinic, between November 2021 and December 2022, were included in this prospective study. Venous Clinical Severity Score (VCSS) values were calculated. The patients were divided into two groups according to their VCSS values (Group 1: VCSS ≤6 and Group 2: VCSS >6).
RESULTS: There were 110 patients in Group 1 with a median age of 42 (18-50) years. There was no difference between the groups in terms of gender, smoking, hypertension frequency, height, weight, body mass index, hemoglobin values, lymphocyte, neutrophil, mean platelet volume, urea, creatinine, high-density lipoprotein, low-density lipoprotein, triglyceride, and total cholesterol values (p > .05). Multivariate logistic regression analysis was performed to reveal the predictive factors of high VCSS values in patients. As a result of the analysis, VAI (Odds Ratio (OR): 1.775; 95% Confidence Interval (CI): 1.389-2.269; p < .001) and CRP (OR: 2.641; 95% CI: 1.431-4.875; p = .002) values were identified as independent predictors in predicting high VCSS values.
CONCLUSION: This current study showed that high VAI values affect clinical complaints in patients with low-grade CVI. In line with our results, clinical recommendations can be made to reduce VAI values in low-stage CVI patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Vascular - (2023) vom: 06. Nov., Seite 17085381231214818 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Eskici, Haci [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic venous insufficiency |
|---|
| Anmerkungen: |
Date Revised 06.11.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1177/17085381231214818 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364234059 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364234059 | ||
| 003 | DE-627 | ||
| 005 | 20231226095019.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/17085381231214818 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1214.xml |
| 035 | |a (DE-627)NLM364234059 | ||
| 035 | |a (NLM)37931595 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Eskici, Haci |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Investigation of the effect of visceral adiposity index on venous clinical severity score in patients with chronic venous insufficiency |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a INTRODUCTION: Chronic venous insufficiency (CVI) is a common disease affecting millions worldwide. Age, obesity, female gender, sedentary life, and long-standing at work causing orthostasis have been identified as predisposing factors | ||
| 520 | |a OBJECTIVE: The visceral adiposity index (VAI) is an important indicator of abdominal obesity. Various studies in the cardiovascular field have shown that it may be more predictive than body mass index (BMI) | ||
| 520 | |a METHODS: A total of 171 consecutive patients diagnosed with low-grade (C0-C3) superficial primary CVI in our clinic, between November 2021 and December 2022, were included in this prospective study. Venous Clinical Severity Score (VCSS) values were calculated. The patients were divided into two groups according to their VCSS values (Group 1: VCSS ≤6 and Group 2: VCSS >6) | ||
| 520 | |a RESULTS: There were 110 patients in Group 1 with a median age of 42 (18-50) years. There was no difference between the groups in terms of gender, smoking, hypertension frequency, height, weight, body mass index, hemoglobin values, lymphocyte, neutrophil, mean platelet volume, urea, creatinine, high-density lipoprotein, low-density lipoprotein, triglyceride, and total cholesterol values (p > .05). Multivariate logistic regression analysis was performed to reveal the predictive factors of high VCSS values in patients. As a result of the analysis, VAI (Odds Ratio (OR): 1.775; 95% Confidence Interval (CI): 1.389-2.269; p < .001) and CRP (OR: 2.641; 95% CI: 1.431-4.875; p = .002) values were identified as independent predictors in predicting high VCSS values | ||
| 520 | |a CONCLUSION: This current study showed that high VAI values affect clinical complaints in patients with low-grade CVI. In line with our results, clinical recommendations can be made to reduce VAI values in low-stage CVI patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Chronic venous insufficiency | |
| 650 | 4 | |a obesity | |
| 650 | 4 | |a symptom | |
| 650 | 4 | |a visceral adiposity | |
| 700 | 1 | |a Engin, Mesut |e verfasserin |4 aut | |
| 700 | 1 | |a Eris, Cüneyt |e verfasserin |4 aut | |
| 700 | 1 | |a Aydın, Ufuk |e verfasserin |4 aut | |
| 700 | 1 | |a Ata, Yusuf |e verfasserin |4 aut | |
| 700 | 1 | |a Yavuz, Şenol |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Vascular |d 2004 |g (2023) vom: 06. Nov., Seite 17085381231214818 |w (DE-627)NLM148188583 |x 1708-539X |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:06 |g month:11 |g pages:17085381231214818 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/17085381231214818 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 06 |c 11 |h 17085381231214818 | ||